Company intelligence / Profile preview
Talengen Institute of Life Sciences
Chinasg.linkedin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Talengen Institute of Life Sciences is a China-based biotechnology company developing biological products for neurological and vascular diseases. Its lead programs are in preclinical through Phase 2 stages, with a focus on amyotrophic lateral sclerosis and chronic limb-threatening ischemia. No published clinical results are available as of the latest updates[1][4].
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Biological products
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Talengen Institute of Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Talengen Institute of Life Sciences.